SCHEMBL3093359

SCHEMBL3093359

CC(C)CC1OCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14777798 0.95
SCHEMBL3217381 0.89
SCHEMBL13243822 0.80
SCHEMBL3947684 0.80
SCHEMBL9735047 0.77
SCHEMBL15821758 0.77 LMNA (0.43)
SCHEMBL15821761 0.77 LMNA (0.43)
SCHEMBL14006393 0.75 HTT (0.30)
SCHEMBL469525 0.75
SCHEMBL10781770 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030089885-A1 Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids SENOMYX, INC. 2003-05-15 US claimed
WO-2002085294-A2 USE OF LOW MOLECULAR WEIGHT ACETAL, ALCOHOL, ACYLATED ALCOHOL AND ESTER COMPOUNDS TO BLOCK OR REDUCE ODOR OF CARBOXYLIC ACIDS SENOMYX, INC. (US) 2002-10-31 WO claimed
US-11584734-B2 Tricyclic compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-02-21 US disclosed
US-20200361896-A1 TRICYCLIC COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2020-11-19 US disclosed
US-10000508-B2 Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate SHIONOGI & CO., LTD (JP) 2018-06-19 US disclosed
US-10000508-B2 Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate SHIONOGI & CO., LTD (JP) 2018-06-19 US disclosed
US-9969750-B2 Method of producing (3S,11aR)-6,8-dihalo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-diones SHIONOGI AND CO., LTD. (JP) 2018-05-15 US disclosed
US-9969750-B2 Method of producing (3S,11aR)-6,8-dihalo-3-methyl-2,3,11,11a-tetrahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-5,7-diones SHIONOGI AND CO., LTD. (JP) 2018-05-15 US disclosed
US-20180044351-A1 METHODS OF PRODUCING COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2018-02-15 US disclosed
US-20180044351-A1 METHODS OF PRODUCING COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2018-02-15 US disclosed
US-20180037591-A1 METHODS OF PRODUCING COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2018-02-08 US disclosed
US-20120022251-A1 METHOD OF PRODUCING PYRONE AND PYRIDONE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2012-01-26 US disclosed
US-20100228058-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2010-09-09 US disclosed
US-7595299-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2009-09-29 US disclosed
WO-2007097719-A1 CYCLISATION PROCESS OF FORMING A MULTIPLE RING COMPOUND NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2007-08-30 WO disclosed
EP-1748800-A1 ODOUR REDUCTION COMPOSITIONS Quest International Services B.V. (NL) 2007-02-07 EP disclosed
US-7169760-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION (US) 2007-01-30 US disclosed
WO-2005110499-A1 ODOR REDUCTION COMPOSITIONS QUEST INTERNATIONAL SERVICES B.V. (NL) 2005-11-24 WO disclosed
US-20030089885-A1 Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids SENOMYX, INC. 2003-05-15 US disclosed
WO-2002085294-A2 USE OF LOW MOLECULAR WEIGHT ACETAL, ALCOHOL, ACYLATED ALCOHOL AND ESTER COMPOUNDS TO BLOCK OR REDUCE ODOR OF CARBOXYLIC ACIDS SENOMYX, INC. (US) 2002-10-31 WO disclosed